Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)

References

• Bagust A, Hopkinson PK, Maier W, et al. An economic model of the long-term health care burden of Type II diabetes. Diabetologia 2001;44:2140–55
   PubMed Web of Science ®Google Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004;20(Suppl 1):S5–S26
   PubMedGoogle Scholar
• Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 1997;20:725–34
   PubMed Web of Science ®Google Scholar
• Eastman RC, Javitt JC, Herman WH, et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 1997;20:735–44
   Google Scholar
• Brown JB, Palmer AJ, Bisgaard P, et al. The Mt. Hood challenge: cross-testing two diabetes simulation models. Diabetes Res Clin Pract 2000;50(Suppl 3):S57–S64
   Google Scholar
• Currie CJ, Morgan CLl, Dixon S, et al. Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before death. Diabetes Res Clin Pract 2005:67;144–51
   PubMed Web of Science ®Google Scholar
• Currie CJ, Morgan CLl, Dixon S, et al. The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications. Diabetes Res Clin Pract 2005:67;144–51
   PubMed Web of Science ®Google Scholar
• Evans M, McEwan P, Peters JR, et al. Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate. Diabetes Obes Metab 2004;6:299–307
   PubMed Web of Science ®Google Scholar
• Soedamah-Muthu SS, Chaturvedi N, Toeller M, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 2004;27: 530–37
   Google Scholar
• Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J 1991;12:293–8
   Web of Science ®Google Scholar
• Stevens RJ, Kothari V, Adler AI, Stratton IM. United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2000;101: 671–9
   Google Scholar
• Kothari V, Stevens RJ, Adler AI, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002;33:1776–81
   PubMed Web of Science ®Google Scholar
• Currie CJ, McEwan P, Peters JR, et al. The Routine Collation of Health Outcomes Data from Hospital Treated Subjects in the Health Outcomes Data Repository (HODaR): Descriptive Analysis from the First 20,000 Subjects. Value Health 2005;8:581–90
   PubMed Web of Science ®Google Scholar
• Clarke P, Gray A, Legood R, et al. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Med 2003;20:442–50
   PubMed Web of Science ®Google Scholar
• Currie CJ, Morgan CL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy and ulceration in diabetes. Diabetes Care 1998;21:42–8
   Google Scholar
• British National Formulary [online]. Available from www.bnf.org/ [Last Accessed 2 Feb 2004)
   Google Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Brit Med J 2000;321:405–12
   PubMed Web of Science ®Google Scholar
• Morgan CL, Curie CJ, Peters J. Relationship between diabetes and mortality. Diabetes Care 2000;23:1103–7
   PubMedGoogle Scholar
• Currie CJ, Morgan CL, Gill L, et al. Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations. Stroke 1997;28:1142–6
   PubMed Web of Science ®Google Scholar
• Currie CJ, Morgan CL, Peters JR. Patterns and costs of hospital care for coronary heart disease related and not related to diabetes. Heart 1997;78:544–9
   Google Scholar
• Palmer AJ, Roze S, Valentine WJ, et al. Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model. Curr Med Res Opin 2004;20(Suppl 1):S53–S58
   Google Scholar
• The CDC Diabetes Cost-Effectiveness Group. Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model. JAMA 2002;287:2542–51
   PubMed Web of Science ®Google Scholar
• Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ 2005;14:217–30
   PubMed Web of Science ®Google Scholar
• Clarke P, Grau A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002;22: 340–9
   Google Scholar
• Lee AJ, Morgan CLl, Morrissey M, et al. Evaluation of the association between the EQ-5D index (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes. Diabet Med 2005;22:1482–6
   PubMed Web of Science ®Google Scholar
• Davis RE, Morrissey M, Peters JR, et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005;21:1477–83
   PubMed Web of Science ®Google Scholar
• Currie CJ, McEwan M, Poole CD, et al. The impact of the overactive bladder on health-related utility and quality of life. BJU International (in press)
   Google Scholar
• Lee AJ, Morgan CLl, Conway P, et al. Characterisation and comparison of health-related quality of life for patients with renal failure. Curr Med Res Opin 2005;21:1777–83
   PubMed Web of Science ®Google Scholar